Pfizer gets mixed results on psoriasis study; Sample6 raises $11M; Alkermes preps for PhIII launch;

@FierceBiotech: Popular from FierceCRO - Analyst: Bet on another boom for big CROs. Story | Follow @FierceBiotech

@JohnCFierce: ICYMI: 10 top drugs in biopharma's late-stage pipeline. Special report | Follow @JohnCFierce

@DamianFierce: Time to find out whether device firms are allowed at the biotech IPO party: LDR prices a $75M debut. News | Follow @DamianFierce

@EmilyMFierce: Altered antimicrobials could combat drug-resistant bacteria. ICYMI from FierceBiotech Research | Follow @EmilyMFierce

> Pfizer ($PFE) today revealed that its late-stage showdown comparing tofacitinib with Enbrel for psoriasis hit the non-inferior endpoint at the high dose but failed at the low dose. Release

> Canaan Partners has led an $11 million round for Sample6, a Boston based biotech focused on food safety. Release

> Alkermes ($ALKS) reports that it's ready to push into Phase III early next year with ALKS-5461, a new treatment for major depression. Release

Medical Device News

@FierceMedDev: ICYMI: Med tech's hottest takeover targets for the rest of 2013. Special report | Follow @FierceMedDev

> Boston Scientific touts positive data for PAD catheter. More

> Medtronic jumps into hemodialysis business through India partnership. Story

> Medtronic wins FDA panel support to expand pacemaker and defibrillator use. Item

Pharma News

@FiercePharma: Tops this AM on our website: Novartis eyes sell-offs, with decision on individual units expected soon. More | Follow @FiercePharma

@EricPFierce: Ranbaxy shopping for FDA approved plant. Article | Get all FiercePharmaManufacturing headlines via email | Follow @EricPFierce

@CarlyHFierce: GSK has always said it would be difficult to copy its respiratory drug Advair--and Teva agrees. Article | Follow @CarlyHFierce

> Former Lilly scientists indicted for passing R&D secrets to Chinese drugmaker. More

> Drugmakers want to block Maine from cheaper Canadian drugs. News

> Who'd like Tom Hanks to be their diabetes role model? Story

Drug Delivery News

@MichaelGFierce: Stem cell 'drug factories' target, treat inflammation. More | Follow @MichaelGFierce

> U.S.-based scientists win Nobel Prize for cell transport exploration. Item

> Study: Disc-shaped nanoparticles best at crossing cell membranes. More

> Cook touts positive data for Zilver paclitaxel-eluting stent after April recall. Story

> Alnylam posts positive PhI for RNAi cholesterol drug. Report

Diagnostics News

@MarkHFierce: Sign up for your free, weekly dose of FierceDiagnostics. Sign up here | Follow @MarkHFierce

> Roche looks to the future with two new molecular Dx systems. Article

> Exact Sciences denies talks underway to invest in Israeli cancer Dx startup. Story

> Boreal Genomics pulls in $18M Series C for genomic research and Dx test expansion. Report

> Renishaw Diagnostics seals deal with tech transfer group to develop infectious disease tests. More

And Finally… A new Rand study concludes that the ability to deliver high-quality care is a major factor in determining job satisfaction for a physician. A major source of dissatisfaction: Electronic medical records. Release

Suggested Articles

Researchers are studying the retrovirus KoRV-A, which is spreading among koalas, to gain new insights into how DNA evolves.

Shionogi and Hsiri Therapeutics first joined forces last year in a licensing and R&D deal focused on tuberculosis and non-tuberculous lung infections.

The efficacy results suggest the experimental oral therapy, abrocitinib, has a shot at challenging the blockbuster biologic incumbent.